A detailed history of Eagle Bay Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 7,889 shares of PFE stock, worth $209,531. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,889
Previous 7,840 0.63%
Holding current value
$209,531
Previous $219,000 4.11%
% of portfolio
0.13%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$27.7 - $31.39 $1,357 - $1,538
49 Added 0.63%
7,889 $228,000
Q2 2024

Jul 26, 2024

BUY
$25.26 - $29.6 $16,343 - $19,151
647 Added 8.99%
7,840 $219,000
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $33,320 - $38,262
1,287 Added 21.79%
7,193 $199,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $54,089 - $70,255
-2,070 Reduced 25.95%
5,906 $170,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $81,508 - $95,275
2,540 Added 46.73%
7,976 $264,000
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $128,876 - $149,106
-3,568 Reduced 39.63%
5,436 $199,000
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $58,494 - $76,150
-1,485 Reduced 14.16%
9,004 $367,000
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $501 - $654
12 Added 0.11%
10,489 $0
Q3 2022

Nov 22, 2022

SELL
$43.76 - $53.42 $78,286 - $95,568
-1,789 Reduced 14.59%
10,477 $460,000
Q2 2022

Aug 19, 2022

BUY
$46.53 - $55.17 $32,989 - $39,115
709 Added 6.13%
12,266 $643 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $408,501 - $506,185
8,929 Added 339.76%
11,557 $598,000
Q4 2021

Jan 21, 2022

SELL
$41.32 - $61.25 $331,055 - $490,735
-8,012 Reduced 75.3%
2,628 $155,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $203,001 - $260,772
5,172 Added 94.59%
10,640 $459,000
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $196,355 - $222,438
5,468 New
5,468 $217,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.